Electrophoresis Equipment and Supplies Market Size, Share and Growth Outlook, 2026

Electrophoresis Equipment and Supplies Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Electrophoresis Equipment and Supplies Market size is forecast to increase from $3.81 Billion in 2026 to $6.03 Billion in 2034 at a CAGR of 5.9% between 2026 and 2034.

The Electrophoresis Equipment and Supplies market report provides detailed analysis and outlook of Electrophoresis Equipment and Supplies segments including By Product Type (Gel Electrophoresis Systems, Capillary Electrophoresis Systems, Electrophoresis Power Supplies, Reagents and Consumables, Software and Imaging Systems ), By Application (Genomics, Proteomics, Clinical Diagnostics, Forensic Analysis, Quality Control and Process Validation), By Workflow Stage (Sample Preparation, Separation, Visualization and Analysis), By End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Hospitals and Medical Centers, Forensic Laboratories) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Electrophoresis Equipment and Supplies Industry Overview

Expansion of Reagents and Sample Preparation Ecosystems

The electrophoresis equipment and supplies industry is evolving through expansion of integrated reagent and sample preparation ecosystems that support advanced laboratory workflows. Companies such as SERVA Electrophoresis GmbH are strengthening their portfolios by securing global distribution rights for specialized reagents used in tissue dissociation and cell isolation. These developments enhance laboratory efficiency by ensuring consistent availability of high-quality biochemical reagents essential for electrophoresis-based research applications. The growing integration of reagents with analytical workflows supports improved reproducibility in molecular biology and biomedical research.

Increasing Adoption of Integrated and Automated Electrophoresis Platforms

Electrophoresis systems are transitioning from traditional manual workflows toward integrated, automated platforms that combine multiple laboratory functions. New-generation systems incorporate gel electrophoresis and imaging into unified devices, eliminating manual gel preparation and reducing operational complexity. These platforms significantly improve workflow efficiency in nucleic acid verification and routine molecular analysis. Automation is becoming a key driver of adoption in both academic and clinical laboratories, where demand for faster turnaround times and simplified workflows continues to increase.

Stable Academic Demand and Education-Focused Product Bundling

Demand for electrophoresis equipment remains stable within academic and teaching laboratories, supported by structured curriculum integration and standardized experimental protocols. Manufacturers are increasingly bundling hardware systems with training materials and educational resources to facilitate adoption in higher education environments. This approach supports hands-on learning in molecular biology, genomics, and biochemistry, while ensuring consistent experimental outcomes. Education-focused product strategies are helping maintain steady market penetration despite fluctuations in research funding cycles.

Shift Toward High-Throughput and AI-Enabled Analytical Systems

A significant transformation in the electrophoresis industry is the shift toward high-throughput capillary electrophoresis systems with enhanced automation and analytical precision. Manufacturers are developing platforms that offer improved resolution, reproducibility, and reduced sample preparation time, particularly for genomics and clinical diagnostics applications. Integration of artificial intelligence into electrophoresis and diagnostic platforms is further enhancing data analysis capabilities and workflow optimization. This technological evolution is enabling laboratories to handle larger sample volumes while maintaining high analytical accuracy and operational efficiency.

Electrophoresis Equipment and Supplies Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Electrophoresis Equipment and Supplies market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation (Beckman Coulter Life Sciences), Merck KGaA (Sigma-Aldrich), QIAGEN N.V., Shimadzu Corporation, PerkinElmer, Inc. (Revvity), Takara Bio Inc., Cleaver Scientific Ltd.. The Electrophoresis Equipment and Supplies market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Electrophoresis Equipment and Supplies industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Electrophoresis Equipment and Supplies Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Electrophoresis Equipment and Supplies companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Electrophoresis Equipment and Supplies markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Electrophoresis Equipment and Supplies Market Competitive Benchmarking and Company Analysis

Leading companies in Electrophoresis Equipment and Supplies industry include- Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation (Beckman Coulter Life Sciences), Merck KGaA (Sigma-Aldrich), QIAGEN N.V., Shimadzu Corporation, PerkinElmer, Inc. (Revvity), Takara Bio Inc., Cleaver Scientific Ltd.. The Electrophoresis Equipment and Supplies market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Electrophoresis Equipment and Supplies Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Electrophoresis Equipment and Supplies market remains one of the strongest-performing segments in the country.
The US Electrophoresis Equipment and Supplies Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Electrophoresis Equipment and Supplies market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Electrophoresis Equipment and Supplies industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Electrophoresis Equipment and Supplies markets

Canada's strong Electrophoresis Equipment and Supplies sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Electrophoresis Equipment and Supplies market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Electrophoresis Equipment and Supplies Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Electrophoresis Equipment and Supplies market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Electrophoresis Equipment and Supplies population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Electrophoresis Equipment and Supplies industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Electrophoresis Equipment and Supplies market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Electrophoresis Equipment and Supplies sales through 2034

France Electrophoresis Equipment and Supplies companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Electrophoresis Equipment and Supplies Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Electrophoresis Equipment and Supplies distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Electrophoresis Equipment and Supplies Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Electrophoresis Equipment and Supplies market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Electrophoresis Equipment and Supplies industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Electrophoresis Equipment and Supplies industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Electrophoresis Equipment and Supplies Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Electrophoresis Equipment and Supplies market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Electrophoresis Equipment and Supplies market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Electrophoresis Equipment and Supplies Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Electrophoresis Equipment and Supplies Market Segmentation

By Product Type
Gel Electrophoresis Systems
Capillary Electrophoresis Systems
Electrophoresis Power Supplies
Reagents and Consumables
Software and Imaging Systems
By Application
Genomics
Proteomics
Clinical Diagnostics
Forensic Analysis
Quality Control and Process Validation
By Workflow Stage
Sample Preparation
Separation
Visualization and Analysis
By End-User
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
Hospitals and Medical Centers
Forensic Laboratories

Top Companies in Electrophoresis Equipment and Supplies Industry

Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Danaher Corporation (Beckman Coulter Life Sciences)
Merck KGaA (Sigma-Aldrich)
QIAGEN N.V.
Shimadzu Corporation
PerkinElmer, Inc. (Revvity)
Takara Bio Inc.
Cleaver Scientific Ltd.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025